Charles Ryan

Charles Ryan

President at QUINCE THERAPEUTICS, INC.

Net worth: 78 518 $ as of 2024-03-30

60 year
Health Technology
Commercial Services
Consumer Services

Profile

Charles S.
Ryan
is currently the Director at GlycoMira LLC and a Member at New York State Bar Association.
He is also the President at Quince Therapeutics, Inc. and a Trustee at The College of Wooster.
Previously, he served as the President, Chief Executive Officer & Director at Orthobond Corp., Chief Executive Officer & Director at Neurotrope, Inc., and Chief Executive Officer & Director at Synaptogenix, Inc. He was also the President, Chief Executive Officer & Director at Travecta Therapeutics Pte Ltd.
and Petros Pharmaceuticals, Inc. Additionally, he served as the Chairman-Development Council at Stony Brook University Medical Center, Independent Director at Applied DNA Sciences, Inc., Director at New York Biotechnology Association, Inc., and Independent Director at BioRestorative Therapies, Inc. He was also a Director at ABS Materials, Inc. and GlycoMira Therapeutics, Inc. Furthermore, he served as the Chief Intellectual Property Counsel & Senior VP at Forest Laboratories, Inc. and Vice President & General Counsel at Engelhard Long Island, Inc. He was also the Chief Operating Officer at LAB21, Inc. and Vice President & General Counsel at Cold Spring Harbor Laboratory, Inc. Dr. Ryan holds a doctorate degree from Stony Brook University, a graduate degree from Western New England University School of Law, and an undergraduate degree from The College of Wooster.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-01-31 74,074 ( 0.17% ) 78 518 $ 2024-03-30

Charles Ryan active positions

CompaniesPositionStart
QUINCE THERAPEUTICS, INC. President 2023-08-31
GlycoMira LLC Director/Board Member -
The College of Wooster Director/Board Member -
Corporate Officer/Principal -
All active positions of Charles Ryan

Former positions of Charles Ryan

CompaniesPositionEnd
Chief Executive Officer 2022-09-30
SYNAPTOGENIX, INC. Chief Executive Officer 2020-11-30
NEUROTROPE, INC. Chief Executive Officer 2020-11-30
BIORESTORATIVE THERAPIES, INC. Director/Board Member 2020-01-09
APPLIED DNA SCIENCES, INC. Director/Board Member 2019-11-06
See the detail of Charles Ryan's experience

Training of Charles Ryan

Stony Brook University Doctorate Degree
Western New England University School of Law Graduate Degree
The College of Wooster Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Charles Ryan's experience

Connections

100 +

1st degree connections

22

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
APPLIED DNA SCIENCES, INC.

Health Technology

BIORESTORATIVE THERAPIES, INC.

Health Technology

SYNAPTOGENIX, INC.

Health Technology

QUINCE THERAPEUTICS, INC.

Health Technology

PETROS PHARMACEUTICALS

Health Technology

Private companies13

Health Technology

Process Industries

GlycoMira LLC

Health Technology

Commercial Services

Health Services

Commercial Services

Commercial Services

Commercial Services

Health Services

Consumer Durables

Technology Services

Health Technology

See company connections